Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Ethicon Vaginal Mesh Plaintiffs Say Company Destroyed, Lost Key Files January 21, 2014 Austin Kirk Add Your Comments A hearing has been scheduled for later this week in response to a motion for sanctions filed by Plaintiffs pursuing vaginal mesh lawsuits against Johnson & Johnson subsidiary Ethicon, which allege that the company has destroyed “a veritable tome” of data that was relevant to the ongoing litigation involving thousands of women nationwide. There are currently more than 11,000 Ethicon Gynecare mesh lawsuits pending against Johnson & Johnson in the federal court system, which have been centralized as part of a multidistrict litigation (MDL) before U.S. District Judge Joseph Goodwin in the Southern District of West Virginia. All of the complaints involve similar allegations that women suffered devastating injuries from transvaginal mesh products made by Ethicon, which were used for surgical treatment of pelvic organ prolapse (POP) or female stress urinary incontinence (SUI). Plaintiffs allege that design defects led to the mesh to eroding through the vagina, causing infections and other painful injuries. Learn More About Vaginal Mesh / Bladder Sling Lawsuits Complications from transvaginal mesh may cause severe injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Vaginal Mesh / Bladder Sling Lawsuits Complications from transvaginal mesh may cause severe injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Last month, plaintiffs filed a Motion for Sanctions (PDF) against the Johnson & Johnson subsidiary, alleging that Ethicon destroyed or lost thousands, or even hundreds of thousands, of key documents that should have been preserved. On December 27, a Supplement (PDF) was filed to the motion, indicating that Plaintiffs discovered after their initial motion on spoilation that a large number of additional documents have been destroyed, lost or simply cannot be found. The latest supplement indicates that in addition to the documents of more than a dozen corporate executives and marketing personnel, the company has also lost the files from John Clay, a regulatory affairs manager who was in charge of the company’s vaginal mesh products in 2006 and 2007; Kendra Munchel, a global marketing manager from 2005-2007 who was one of the employees in charge of professional education on the launch of some of the company’s vaginal mesh product lines, as well as several others who were involved at various points with the development and marketing of Ethicon vaginal mesh products. “For the sake of these MDL proceedings and comparable future litigation, Defendants should not be tacitly rewarded for thwarting the rules and principles of discovery and making Plaintiffs’ task difficult if not impossible, depending on what juries would find without sanctions,” according to the motion filed by plaintiffs, which indicates that “severe and punitive sanctions are clearly warranted in this case.” In a response (PDF) filed on January 10, Ethicon denied the charges and said it has been diligent in responding to requests. However the company admitted some of its employees had erred in document preservation protocols. “In Spring 2013, attorneys for Ethicon discovered that certain Company employees’ electronic documents were inadvertently not retained upon the employees’ departure from the Company despite Ethicon’s clear, written document retention policies,” the company’s attorneys wrote. “After some investigation, Ethicon determined that the inadvertent deletion of these materials resulted primarily from a misunderstanding by certain employees regarding who was responsible for retaining documents potentially relevant to litigation at the end of an employee’s tenure at Ethicon.” The company claims many of the documents that were supposedly lost were available through other means. In a pretrial order (PDF) issued January 17, a hearing on the motion was scheduled for Thursday before U.S. Magistrate Judge Cheryl Eifert. Ethicon Vaginal Mesh Lawsuits Ethicon is one of at least six manufacturers that face similar lawsuits over vaginal mesh complications, with thousands of additional claims pending against C.R. Bard, American Medical Systems (AMS), Boston Scientific, Coloplast Corp. and Cook Medical. The majority of the vaginal mesh litigation in the country has been centralized for pretrial proceedings before Judge Goodwin, where the cases are being coordinated during the discovery phase and a series of early trial dates, known as “bellwether” cases, which are designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout other cases. According to a case list (PDF) released by the U.S. Judicial Panel on Multidistrict Litigation on January 15, Judge Goodwin is currently presiding over 11,400 AMS mesh lawsuits, 11,667 cases involving Ethicon mesh, 7,377 Boston Scientific mesh lawsuits, 5,516 Bard Avaulta mesh lawsuits, 1,106 Coloplast mesh lawsuits and 150 Cook Medical mesh lawsuits. In addition to the federal litigation, thousands of additional cases are also pending in various state court systems. At least another 4,549 Ethicon Gynecare mesh lawsuits and 915 Bard mesh lawsuits are pending in New Jersey, where the cases have also been centralized for coordinated handling before one state court judge. In each of the coordinated proceedings involving different manufacterers, a small group of cases are currently being prepared for early trial dates, known as “bellwether” cases. These cases are designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout similar cases. At least four vaginal mesh cases have already reached trial, with two cases going before state court juries and two cases proceeding to trial in federal court. In July 2012, a California state court jury awarded $5.5 million in damages against C.R. Bard and a New Jersey state court jury awarded $11.1 million in damages against Ethicon in March 2013. In July 2013, a federal jury awarded $2 million in damages against Bard, including punitive damages designed to punish the manufacturer for their actions surrounding the design and sale of vaginal mesh products. A second Bard case settled during the first day of trial for an undisclosed sum. An Ethicon mesh trial is currently scheduled to begin on February 10, involving a lawsuit filed by Carolyn Lewis, who experienced problems with a Gynecare TVT sling. That will be followed by a series of other trials involving products manufactured Boston Scientific and AMS, with about one case-per-month set to begin over the next nine months. As a result of the spoliation of evidence by Ethicon, Plaintiffs have requested a default judgement be entered in all bellwether cases, indicating that the Court should strike Ethicon’s learned intermediary defense and give the jury an instruction regarding the presumption to be inferred from the failure of the manufacturer to preserve evidence. The outcomes of these early trial dates being closely watched by lawyers involved in the litigation, as the outcomes may influence future vaginal mesh settlement negotiations in other cases. Tags: Bladder Sling, Ethicon, Gynecare, Johnson & Johnson, Transvaginal Mesh, Vaginal Mesh More Vaginal Mesh Lawsuit Stories Study Finds Some Transvaginal Mesh Degrades Within 2 Months After It Is Implanted October 29, 2024 Supreme Court Rejects J&J Bid to Overturn $302M Vaginal Mesh Lawsuit Award February 23, 2023 Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study January 16, 2023 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: yesterday) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025) Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: 2 days ago) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 3 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Recalled Medical Devices Fast-Tracked Through FDA Approval Process Were Often Based on Flawed, Older Designs: Study January 16, 2023
Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: yesterday) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025)
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: 2 days ago) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 3 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)